KR102274147B9 - 텔미사르탄을 포함하는 단층정 복합 제제 - Google Patents

텔미사르탄을 포함하는 단층정 복합 제제

Info

Publication number
KR102274147B9
KR102274147B9 KR1020197004694A KR20197004694A KR102274147B9 KR 102274147 B9 KR102274147 B9 KR 102274147B9 KR 1020197004694 A KR1020197004694 A KR 1020197004694A KR 20197004694 A KR20197004694 A KR 20197004694A KR 102274147 B9 KR102274147 B9 KR 102274147B9
Authority
KR
South Korea
Prior art keywords
formulation containing
layer tablet
combination formulation
containing telmisartan
tablet combination
Prior art date
Application number
KR1020197004694A
Other languages
English (en)
Other versions
KR20190028533A (ko
KR102274147B1 (ko
Inventor
박석용
지현구
최주환
최성업
조성완
황성주
Original Assignee
주식회사 인트로바이오파마
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 인트로바이오파마 filed Critical 주식회사 인트로바이오파마
Priority to KR1020197004694A priority Critical patent/KR102274147B1/ko
Publication of KR20190028533A publication Critical patent/KR20190028533A/ko
Application granted granted Critical
Publication of KR102274147B1 publication Critical patent/KR102274147B1/ko
Publication of KR102274147B9 publication Critical patent/KR102274147B9/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020197004694A 2016-08-11 2016-08-11 텔미사르탄을 포함하는 단층정 복합 제제 KR102274147B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020197004694A KR102274147B1 (ko) 2016-08-11 2016-08-11 텔미사르탄을 포함하는 단층정 복합 제제

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020197004694A KR102274147B1 (ko) 2016-08-11 2016-08-11 텔미사르탄을 포함하는 단층정 복합 제제
PCT/KR2016/008842 WO2018030559A1 (ko) 2016-08-11 2016-08-11 텔미사르탄을 포함하는 단층정 복합 제제

Publications (3)

Publication Number Publication Date
KR20190028533A KR20190028533A (ko) 2019-03-18
KR102274147B1 KR102274147B1 (ko) 2021-07-08
KR102274147B9 true KR102274147B9 (ko) 2022-03-28

Family

ID=61162348

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197004694A KR102274147B1 (ko) 2016-08-11 2016-08-11 텔미사르탄을 포함하는 단층정 복합 제제

Country Status (3)

Country Link
KR (1) KR102274147B1 (ko)
CN (1) CN109562074A (ko)
WO (1) WO2018030559A1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112569241B (zh) * 2019-09-27 2021-11-02 武汉武药科技有限公司 替米沙坦氢氯噻嗪双层片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1467712E (pt) * 2002-01-16 2008-01-09 Boehringer Ingelheim Pharma Comprimido farmacêutico de duas camadas compreendendo telmisartan e hidroclorotiazida
SI1814527T1 (sl) * 2004-11-05 2014-03-31 Boehringer Ingelheim International Gmbh Dvoslojna tableta, ki obsega telmisartan in amlodipin
ES2404939T3 (es) * 2005-06-27 2013-05-29 Daiichi Sankyo Company, Limited Preparación farmacéutica que contiene un antagonista del receptor de la angiotensina II y un bloqueador de los canales de calcio
CN102247367B (zh) * 2011-05-24 2014-05-21 苏州东瑞制药有限公司 一种含替米沙坦氨氯地平药物组合物及制备方法
KR101446603B1 (ko) * 2011-11-22 2014-10-07 주식회사 인트로팜텍 텔미사르탄을 포함하는 단층정 복합 제제
KR101302883B1 (ko) * 2012-07-23 2013-09-05 삼일제약주식회사 텔미사르탄을 유효성분으로 포함하는 안정성이 증가된 약제학적 조성물 및 그 제조방법
KR101736039B1 (ko) * 2012-09-19 2017-05-17 주식회사 인트로팜텍 텔미사르탄을 함유하는 약제학적 조성물 및 이를 포함하는 고형 제제

Also Published As

Publication number Publication date
CN109562074A (zh) 2019-04-02
WO2018030559A1 (ko) 2018-02-15
KR20190028533A (ko) 2019-03-18
KR102274147B1 (ko) 2021-07-08

Similar Documents

Publication Publication Date Title
DK3485237T3 (da) Dosismålesystemer
DK3310414T3 (da) Lægemiddeladministrationsanordning
DK3529240T3 (da) Farmaceutiske forbindelser
DK3634377T3 (da) Farmaceutisk formulering
DK3283058T3 (da) Ribociclib-tablet
DK3189891T3 (da) Kombinationstabletmaskine
DK3340968T3 (da) Implanterbare naltrexon-tabletter
DK3341319T3 (da) Læsseindretning
DK3129006T3 (da) Immunsupprimerende formulering
CL2016002847A1 (es) Extintores cosmicos
UA31197S (uk) Таблетка
KR20180084810A (ko) 정제 세트
DK3193840T3 (da) Arimoclomol-formulering
DK3126791T3 (da) Doseringsanordning
DK3368017T3 (da) Optimeret mesalazinholdig højdosistablet
DK3209224T3 (da) Blisterstrimmel
DK3164174T3 (da) Lægemiddeladministrationsanordning
ES2981002T3 (es) Formulación farmacéutica
DK3215118T3 (da) Lægemiddelanordningsenhed indeholdende quinagolid
DK3641919T3 (da) Doseringsanordning
DK3601277T3 (da) Farmaceutisk formulering
FR3021528B1 (fr) Formulation cosmetique
FI11623U1 (fi) Kuormaa kantava rakenne
CL2016002705A1 (es) Formulación agroquímica
DK3148513T3 (da) Ceritinib-formulering

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
G170 Re-publication after modification of scope of protection [patent]